Atea Pharmaceuticals, Inc. (AVIR) › RevenueAtea Pharmaceuticals, Inc. (AVIR) — RevenueAnnual figures by fiscal year, from SEC filings.2020: $48.63M2021: $351.37M$351.37M2020Revenue (USD)2021Fiscal YearRevenueChange YoY2021$351.37M+622.5%2020$48.63M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share